Alpha-L-Iduronidase

Alternative Names

  • IDUA
  • Iduronidase, Alpha-L
Back to search Result
OMIM Number

252800

NCBI Gene ID

3425

Uniprot ID

P35475

Length

17,568 bases

No. of Exons

16

No. of isoforms

2

Protein Name

Alpha-L-iduronidase

Molecular Mass

72670 Da

Amino Acid Count

653

Genomic Location

chr4:986,996-1,004,563

Gene Map Locus
4p16.3

Description

The IDUA gene encodes an enzyme called alpha-L-iduronidase, which is required for the lysosomal degradation of glycosaminoglycans (GAGs). Specifically, it hydrolyzes the terminal alpha-L-iduronic acid residues - dermatan sulfate and heparan sulfate.

Defects in this enzyme lead to the accumulation of GAGs and result in a lysosomal storage disorder mucopolysaccharidosis type I (MPS I). MPS I is an autosomal recessive disorder that is relentlessly progressive and potentially fatal with a wide spectrum of severity. In some patients, the brain may be affected in combination with physical symptoms; others may develop physical symptoms with no brain involvement.

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
NM_000203.5:c.1868T>CSaudi ArabiaNC_000004.12:g.1004299T>CLikely Pathogenic, PathogenicLikely PathogenicHurler SyndromeNG_008103.1:g.22303T>C; NM_000203.5:c.1868T>C; NP_000194.2:p.Leu623Pro1339514
NM_000203.5:c.192C>APalestinechr4:987842PathogenicPathogenicHurler-Scheie SyndromeNG_008103.1:g.5846C>A; NM_000203.5:c.192C>A; NP_000194.2:p.Tyr64Ter12196502211914
NM_000203.5:c.613_617dupSyriaNC_000004.12:g.1001702_1001706dupPathogenicPathogenicHurler SyndromeNG_008103.1:g.19706_19710dup; NM_000203.5:c.613_617dup; NP_000194.2:p.Glu207AlafsTer2978620091511921
NM_000203.5:c.878_889dupSaudi ArabiaNC_000004.12:g.1002067_1002078dupLikely Pathogenic, PathogenicLikely PathogenicHurler SyndromeNG_008103.1:g.20071_20082dup; NM_000203.5:c.878_889dup; NP_000194.2:p.Thr293_Tyr296dup779762183550382

Other Reports

Morocco

Using fluorescence-assisted mismatch analysis (FAMA) and cycle sequencing of the PCR products, Alif et al. (1999) screened for mutations in the IDUA gene in a group of 13 Moroccan patients with MPS I and their families, including three sibs and twin sibs. The p.P553R mutation, which is rare in Europeans, was identified in 92% of mutant alleles (24 of 26). This was said to be the highest frequency of this mutation detected in patients with Hurler syndrome. None of the patients carried the p.W402X or the p.Q70X allele, the most common MPS I mutations in Europeans.

Palestine

Schaap and Bach (1980) found 13 Arab patients with Hurler syndrome. The patients came from eight families, five of which were Druze and three Muslim. Bach et al. (1993) found homozygosity for three different mutations distributed in seven families, five of them Druze: mutations in exon 2 (p.TYR64TER), exon 7 (p.GLN310TER), and exon 8 (p.THR366PRO). Transfection of mutagenized cDNA into COS-1 cells showed that the missense mutation p.THR366PRO permitted the expression of only trace amounts of alpha-L-iduronidase activity. The nonsense mutations were associated with abnormalities of RNA processing. The p.TYR64TER mutation was accompanied by a very low level of mRNA and skipping of exon 2. Utilization of a cryptic splice site was observed with the p.GLN310TER mutation. Bach et al. (1993) anticipated that MPS in the Druze population would be caused by one founder mutation which might or might not be shared with the Muslim patients residing in the surrounding area. They were surprised to find that, in fact, there were three different mutations and that none of which had been found in Europeans.

© CAGS 2024. All rights reserved.